Revolutionizing Cancer Care: University Hospitals Seidman Cancer Center First in the U.S. to Introduce Akesis Inc.’s Cutting-Edge Galaxy RTI Device

Akesis, Inc., a leader in radiation oncology technology, has teamed up with the University Hospitals Seidman Cancer Center in Cleveland, Ohio. This partnership marks a big step forward for cancer treatment. UH Seidman is the first hospital in the U.S. to use the Akesis Galaxy RTi device, which promises to enhance patient care and treatment outcomes.

This new technology will be a key part of the center’s stereotactic radiosurgery (SRS) program. It aims to improve the precision of treatments for cancer patients. The collaboration will also create opportunities for healthcare professionals to see the Galaxy RTi in action through demonstrations and research efforts.

Lien Pham, Akesis’s VP and COO, expressed excitement about this partnership. “The Galaxy RTi is a major advancement in SRS technology,” he said. “We believe this collaboration will benefit patients everywhere.”

Dr. Daniel Spratt from UH Seidman shares this enthusiasm. He highlighted the center’s commitment to using cutting-edge technologies to improve patient care. “This partnership with Akesis shows our dedication to advancing cancer treatment standards,” he noted.

According to recent data, over 20% of the U.S. population will develop cancer at some point in their lives. This alarming statistic emphasizes the importance of innovative treatments like the Galaxy RTi, which can potentially transform the landscape of radiation therapy. Studies show that precision in radiation treatment can lead to better outcomes and fewer side effects for patients.

Dr. Prashant Vempati and Dr. Tiffany Hodges from UH Seidman stressed the significance of the technology. They see it not just as a treatment tool but as a promise of healing for patients and their families. “This machine represents our commitment to our community,” they said.

Akesis, inspired by the Greek goddess of healing, is dedicated to improving radiation treatments. Their Galaxy RTi combines advanced gamma technology with dynamic treatment delivery. This system allows for more precise targeting of tumors, a shift from traditional fixed delivery methods. It’s also notable for its ability to track patient movements during treatment, enhancing safety and effectiveness.

University Hospitals Seidman Cancer Center is a key player in cancer research and treatment. As part of the National Cancer Institute-designated Case Comprehensive Cancer Center, they are committed to offering the latest in cancer care. With clinics throughout the region, they focus on personalized treatment plans designed for each patient’s unique needs.

The collaboration between Akesis and UH Seidman Cancer Center is set to pave the way for fast-tracked innovation in cancer treatment. By prioritizing advanced technologies, they hope to improve patient outcomes and push the field of cancer care forward.

For more information about Akesis and the Galaxy RTi, visit their website at Akesis and Galaxy RTi.

To explore the University Hospitals system, check out UH Hospitals.

Source link

Newswise, Radiation Oncology;Technology,Cancer, Healthcare, Technology, University Hospitals Cleveland Medical Center